<?xml version="1.0" encoding="UTF-8"?>
<p>Pre‐HCT recipients should be screened for RVI and treated appropriately until resolution of the RVI, since the presence of RVI prior to HCT has been linked with poorer outcomes post‐HCT 
 <xref rid="onco13306-bib-0065" ref-type="ref">65</xref>. European bone marrow transplant panel experts’ recommendations (released on March 1, 2020) for recipients and donors of hematopoietic cells before the beginning of any of the transplant procedures (mobilization, apheresis, marrow harvest, and conditioning) are summarized in Table 
 <xref rid="onco13306-tbl-0002" ref-type="table">2</xref>
 <xref rid="onco13306-bib-0066" ref-type="ref">66</xref>.
</p>
